A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing

被引:4
作者
Kim, Jennifer S. [1 ]
Wood, Robert A. [2 ]
Lindblad, Robert [3 ]
Noone, Sally A. [1 ]
Paterakis, Melissa N. [2 ]
Henning, Alice [3 ]
Nadeau, Kari C. [4 ]
Spann, Kyrsten [4 ]
Sampson, Hugh A. [1 ]
机构
[1] Mt Sinai, Icahn Sch Med, New York, NY USA
[2] Johns Hopkins Univ, Med Ctr, Baltimore, MD 21218 USA
[3] EMMES Corp, Rockville, MD USA
[4] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.jaci.2013.12.1067
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
L19
引用
收藏
页码:AB403 / AB403
页数:1
相关论文
empty
未找到相关数据